Abstract
SUMMARY: Primary progressive aphasia is a clinically and neuropathologically heterogeneous group of progressive neurodegenerative disorders, characterized by language-predominant impairment and commonly associated with atrophy of the dominant language hemisphere. While this clinical entity has been recognized dating back to the 19th century, important advances have been made in defining our current understanding of primary progressive aphasia, with 3 recognized subtypes to date: logopenic variant, semantic variant, and nonfluent/agrammatic variant. Given the ongoing progress in our understanding of the neurobiology and genomics of these rare neurodegenerative conditions, accurate imaging diagnoses are of the utmost importance and carry implications for future therapeutic triaging. This review covers the diverse spectrum of primary progressive aphasia and its multimodal imaging features, including structural, functional, and molecular neuroimaging findings; it also highlights currently recognized diagnostic criteria, clinical presentations, histopathologic biomarkers, and treatment options of these 3 primary progressive aphasia subtypes.
ABBREVIATIONS:
- AD
- Alzheimer disease
- ASL
- arterial spin-labeling
- FTLD
- frontotemporal lobar degeneration
- lvPPA
- logopenic variant PPA
- nfvPPA
- nonfluent/agrammatic variant PPA
- PPA
- primary progressive aphasia
- 3R
- 3-repeat
- 4R
- 4-repeat
- svPPA
- semantic variant PPA
- TDP-43
- transactive-response DNA-binding protein 43
- TSPO
- translocator protein 18 kDa
Footnotes
This work was supported by the Foundation of the American Society of Neuroradiology Boerger Research Fund for Alzheimer’s Disease and Neurocognitive Disorders (2021): “18F PI-2620 in Primary Progressive Aphasia” (Principal Investigator: Ana Franceschi).
Disclosure forms provided by the authors are available with the full text and PDF of this article at www.ajnr.org.
- © 2022 by American Journal of Neuroradiology
Indicates open access to non-subscribers at www.ajnr.org